Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability
NGAL (Neutrophil Gelatinase-Associated Lipocalin) has emerged as a new biomarker for the identification of acute kidney injury. Reliable clinical evaluations require a simple, robust test method for NGAL, and knowledge of specimen handling and specimen stability characteristics. We evaluated the per...
Saved in:
Published in | Clinical biochemistry Vol. 43; no. 6; pp. 615 - 620 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Inc
01.04.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | NGAL (Neutrophil Gelatinase-Associated Lipocalin) has emerged as a new biomarker for the identification of acute kidney injury. Reliable clinical evaluations require a simple, robust test method for NGAL, and knowledge of specimen handling and specimen stability characteristics. We evaluated the performance of a new urine NGAL assay on the ARCHITECT analyzer.
Assay performance characteristics were evaluated using standard protocols. Urine specimen storage requirements were determined and biological variability was assessed in a self-declared apparently healthy population.
Assay performance data showed good precision, sensitivity and lot-to-lot reproducibility. There was good short term 2–8 °C sample stability, however, long term storage samples must be kept at −
70 °C or colder. The largest variance component in a biological variance study was within-day.
The ARCHITECT NGAL assay proved to be a precise and reproducible assay for the determination of urine NGAL. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0009-9120 1873-2933 1873-2933 |
DOI: | 10.1016/j.clinbiochem.2009.12.008 |